Page last updated: 2024-12-10

4-hydroxychalcone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-hydroxychalcone: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

4-hydroxychalcone : A member of the class of chalcones that is trans-chalcone substituted by a hydroxy group at position 4. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5282361
CHEMBL ID7747
CHEBI ID34423
SCHEMBL ID1375837
MeSH IDM0419450

Synonyms (66)

Synonym
BIDD:ER0068
LS-14375
nsc-170282
nsc170282
38239-55-3
2-propen-1-one, 3-(4-hydroxyphenyl)-1-phenyl-
20426-12-4
4-hydroxychalcone
MLS000777850
smr000414187
4-hydroxy chalcone
(2e)-3-(4-hydroxyphenyl)-1-phenylprop-2-en-1-one
nsc 60593
ccris 2228
AKOS001325512
chebi:34423 ,
CHEMBL7747
H0955
2-(4-hydroxybenzal)acetophenone
2-(4-hydroxybenzylidene)acetophenone
3-(4-hydroxyphenyl)-1-phenylprop-2-en-1-one
NCGC00246413-01
(e)-3-(4-hydroxyphenyl)-1-phenylprop-2-en-1-one
4-hydroxybenzylidene acetophenone
A814543
(e)-3-(4-hydroxyphenyl)-1-phenyl-prop-2-en-1-one
chalcone 2
bdbm86004
chalcone, 3
HMS2766F17
nsc 170282
jo97q47vbu ,
unii-jo97q47vbu
3-(4-hydroxyphenyl)-1-phenyl-2-propen-1-one
AE-641/00204063
CCG-214736
SCHEMBL1375837
(e)-3-(4-hydroxyphenyl)-1-phenyl-2-propen-1-one
chalcone, 4-hydroxy-
(e)-4-hydroxychalcone
(4-hydroxybenzylidene)acetophenone
trans-4-hydroxychalcone
2-propen-1-one, 3-(4-hydroxyphenyl)-1-phenyl-, (e)-
2-propen-1-one, 3-(4-hydroxyphenyl)-1-phenyl-, (2e)-
1-phenyl-3-(4-hydroxyphenyl)-2-propen-1-one
(4-hydroxybenzal)acetophenone
3-(4-hydroxy-phenyl)-1-phenyl-prop-2-en-1-one
MS-11494
(2e)-3-(4-hydroxyphenyl)-1-phenyl-2-propen-1-one #
(4-hydroxybenzylidene) acetophenone
4-hydroxystyryl phenyll ketone
t5763121
DTXSID3022453
IPJ ,
4-hydroxy-chalcone
mfcd00016488
Z46028347
HY-107818
yisi
Q27116057
n-a-boc-l-tryptophanbenzylester
STL561451
CS-0030695
S4763
STARBLD0019043
CS-0369633

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
"A total of 30 chalcone analogues was synthesized via a base catalyzed Claisen Schmidt condensation and screened for their in vitro antibacterial activity against Methicillin-sensitive Staphylococcus aureus (MSSA) and Methicillin-resistant Staphylococcus aureus (MRSA) alone or in combination with non beta-lactam antibiotics namely ciprofloxacin, chloramphenicol, erythromycin, vancomycin, doxycycline and gentamicin."( Synthesis and anti Methicillin resistant Staphylococcus aureus activity of substituted chalcones alone and in combination with non-beta-lactam antibiotics.
Do, TH; Huynh, TN; Ngo, TD; Thai, KM; Tran, CD; Tran, NC; Tran, TD, 2012
)
0.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
antihypertensive agentAny drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
chalconesA ketone that is 1,3-diphenylpropenone (benzylideneacetophenone), ArCH=CH(=O)Ar, and its derivatives formed by substitution.
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (39)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency2.68550.007215.758889.3584AID588342
Nrf2Homo sapiens (human)Potency15.84890.09208.222223.1093AID624171
BRCA1Homo sapiens (human)Potency22.38720.89137.722525.1189AID624202
ATAD5 protein, partialHomo sapiens (human)Potency17.35120.004110.890331.5287AID504466; AID504467
TDP1 proteinHomo sapiens (human)Potency32.64270.000811.382244.6684AID686978
hypothetical protein, conservedTrypanosoma bruceiPotency19.95260.223911.245135.4813AID624173
nonstructural protein 1Influenza A virus (A/WSN/1933(H1N1))Potency10.00000.28189.721235.4813AID2326
glucocerebrosidaseHomo sapiens (human)Potency8.91250.01268.156944.6684AID2101
P53Homo sapiens (human)Potency39.81070.07319.685831.6228AID504706
pyruvate kinaseLeishmania mexicana mexicanaPotency12.58930.398113.744731.6228AID1721; AID1722
nuclear factor erythroid 2-related factor 2 isoform 2Homo sapiens (human)Potency29.09290.00419.984825.9290AID504444
importin subunit beta-1 isoform 1Homo sapiens (human)Potency50.11875.804836.130665.1308AID540263
pyruvate kinase PKM isoform aHomo sapiens (human)Potency19.95260.04017.459031.6228AID1631; AID1634
ras-related protein Rab-9AHomo sapiens (human)Potency6.30960.00022.621531.4954AID485297
snurportin-1Homo sapiens (human)Potency50.11875.804836.130665.1308AID540263
histone-lysine N-methyltransferase 2A isoform 2 precursorHomo sapiens (human)Potency63.09570.010323.856763.0957AID2662
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency17.78280.00798.23321,122.0200AID2551
gemininHomo sapiens (human)Potency29.09290.004611.374133.4983AID624296
VprHuman immunodeficiency virus 1Potency50.11871.584919.626463.0957AID651644
Endothelin receptor type BRattus norvegicus (Norway rat)Potency12.58930.562315.160931.6228AID1721
Endothelin-1 receptorRattus norvegicus (Norway rat)Potency12.58930.562315.160931.6228AID1721
Guanine nucleotide-binding protein GHomo sapiens (human)Potency7.07951.995325.532750.1187AID624287
phosphoglycerate kinaseTrypanosoma brucei brucei TREU927Potency15.84890.07578.474229.0628AID602233
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AcetylcholinesteraseTetronarce californica (Pacific electric ray)IC50 (µMol)40.00000.00570.42855.1200AID1799680
60 kDa heat shock protein, mitochondrialHomo sapiens (human)IC50 (µMol)22.00000.17004.559010.0000AID1594139
Androgen receptorRattus norvegicus (Norway rat)IC50 (µMol)47.86300.00101.979414.1600AID255211
Nuclear factor NF-kappa-B p105 subunitHomo sapiens (human)IC50 (µMol)24.00000.00011.97318.0000AID1142307
10 kDa heat shock protein, mitochondrialHomo sapiens (human)IC50 (µMol)22.00000.17004.559010.0000AID1594139
Xanthine dehydrogenase/oxidaseBos taurus (cattle)IC50 (µMol)224.50000.00303.10159.8000AID1272632; AID1461517
Nuclear factor NF-kappa-B p100 subunit Homo sapiens (human)IC50 (µMol)24.00000.00011.80888.0000AID1142307
Transcription factor p65Homo sapiens (human)IC50 (µMol)24.00000.00011.89818.8000AID1142307
Thiosulfate sulfurtransferaseHomo sapiens (human)IC50 (µMol)100.00000.06003.96319.7000AID1594135
60 kDa chaperonin Escherichia coliIC50 (µMol)30.50000.03903.55529.8000AID1594140; AID1594141
10 kDa chaperonin Escherichia coliIC50 (µMol)30.50000.03903.55529.8000AID1594140; AID1594141
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Substance-P receptorCavia porcellus (domestic guinea pig)CD33.00000.90004.50009.8000AID144377
Quinone oxidoreductaseMus musculus (house mouse)CD33.00000.20002.74219.8000AID144377
toxin BClostridioides difficile 630AC5037.060020.870031.260037.0600AID720512
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (189)

Processvia Protein(s)Taxonomy
protein folding60 kDa chaperoninEscherichia coli K-12
response to radiation60 kDa chaperoninEscherichia coli K-12
response to heat60 kDa chaperoninEscherichia coli K-12
virion assembly60 kDa chaperoninEscherichia coli K-12
chaperone cofactor-dependent protein refolding60 kDa chaperoninEscherichia coli K-12
protein refolding60 kDa chaperoninEscherichia coli K-12
chaperone cofactor-dependent protein refolding60 kDa chaperoninEscherichia coli K-12
response to heat60 kDa chaperoninEscherichia coli K-12
adhesion of symbiont to host60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of type II interferon production60 kDa heat shock protein, mitochondrialHomo sapiens (human)
T cell activation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
MyD88-dependent toll-like receptor signaling pathway60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of T cell mediated immune response to tumor cell60 kDa heat shock protein, mitochondrialHomo sapiens (human)
'de novo' protein folding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic process60 kDa heat shock protein, mitochondrialHomo sapiens (human)
response to unfolded protein60 kDa heat shock protein, mitochondrialHomo sapiens (human)
response to cold60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of interferon-alpha production60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of type II interferon production60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of interleukin-10 production60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of interleukin-12 production60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of interleukin-6 production60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein refolding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
B cell proliferation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
B cell activation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of macrophage activation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of apoptotic process60 kDa heat shock protein, mitochondrialHomo sapiens (human)
negative regulation of apoptotic process60 kDa heat shock protein, mitochondrialHomo sapiens (human)
isotype switching to IgG isotypes60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein stabilization60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of T cell activation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
chaperone-mediated protein complex assembly60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein maturation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
biological process involved in interaction with symbiont60 kDa heat shock protein, mitochondrialHomo sapiens (human)
cellular response to interleukin-760 kDa heat shock protein, mitochondrialHomo sapiens (human)
T cell activation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein import into mitochondrial intermembrane space60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein folding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
mitochondrial unfolded protein response60 kDa heat shock protein, mitochondrialHomo sapiens (human)
apoptotic mitochondrial changes60 kDa heat shock protein, mitochondrialHomo sapiens (human)
negative regulation of transcription by RNA polymerase IINuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
positive regulation of transcription by RNA polymerase IINuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
cellular response to lipopolysaccharideNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
negative regulation of transcription by RNA polymerase IINuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
regulation of transcription by RNA polymerase IINuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
transcription by RNA polymerase IINuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
apoptotic processNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
inflammatory responseNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
canonical NF-kappaB signal transductionNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
JNK cascadeNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
negative regulation of gene expressionNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
positive regulation of macrophage derived foam cell differentiationNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
positive regulation of lipid storageNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
negative regulation of calcidiol 1-monooxygenase activityNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
negative regulation of vitamin D biosynthetic processNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
negative regulation of cholesterol transportNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
negative regulation of interleukin-12 productionNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
response to muscle stretchNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
non-canonical NF-kappaB signal transductionNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
negative regulation of apoptotic processNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
positive regulation of DNA-templated transcriptionNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
positive regulation of transcription by RNA polymerase IINuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
negative regulation of inflammatory responseNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
B cell receptor signaling pathwayNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
negative regulation of protein metabolic processNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
mammary gland involutionNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
positive regulation of transcription initiation by RNA polymerase IINuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
cellular response to mechanical stimulusNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
cellular response to nicotineNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
cellular response to interleukin-1Nuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
cellular response to interleukin-6Nuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
cellular response to tumor necrosis factorNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
cellular response to dsRNANuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
positive regulation of canonical Wnt signaling pathwayNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
cellular response to interleukin-17Nuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
cellular response to virusNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
antibacterial innate immune responseNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
positive regulation of hyaluronan biosynthetic processNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
cellular response to angiotensinNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
positive regulation of miRNA metabolic processNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
cellular response to stressNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
innate immune responseNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
response to cytokineNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
positive regulation of cell adhesionStromal cell-derived factor 1Homo sapiens (human)
positive regulation of T cell migrationStromal cell-derived factor 1Homo sapiens (human)
response to hypoxiaStromal cell-derived factor 1Homo sapiens (human)
neuron migrationStromal cell-derived factor 1Homo sapiens (human)
positive regulation of endothelial cell proliferationStromal cell-derived factor 1Homo sapiens (human)
intracellular calcium ion homeostasisStromal cell-derived factor 1Homo sapiens (human)
chemotaxisStromal cell-derived factor 1Homo sapiens (human)
defense responseStromal cell-derived factor 1Homo sapiens (human)
immune responseStromal cell-derived factor 1Homo sapiens (human)
cell adhesionStromal cell-derived factor 1Homo sapiens (human)
signal transductionStromal cell-derived factor 1Homo sapiens (human)
G protein-coupled receptor signaling pathwayStromal cell-derived factor 1Homo sapiens (human)
blood circulationStromal cell-derived factor 1Homo sapiens (human)
regulation of actin polymerization or depolymerizationStromal cell-derived factor 1Homo sapiens (human)
adult locomotory behaviorStromal cell-derived factor 1Homo sapiens (human)
response to virusStromal cell-derived factor 1Homo sapiens (human)
telencephalon cell migrationStromal cell-derived factor 1Homo sapiens (human)
animal organ regenerationStromal cell-derived factor 1Homo sapiens (human)
positive regulation of dopamine secretionStromal cell-derived factor 1Homo sapiens (human)
integrin activationStromal cell-derived factor 1Homo sapiens (human)
chemokine (C-X-C motif) ligand 12 signaling pathwayStromal cell-derived factor 1Homo sapiens (human)
CXCL12-activated CXCR4 signaling pathwayStromal cell-derived factor 1Homo sapiens (human)
response to peptide hormoneStromal cell-derived factor 1Homo sapiens (human)
positive regulation of neuron differentiationStromal cell-derived factor 1Homo sapiens (human)
positive regulation of axon extension involved in axon guidanceStromal cell-derived factor 1Homo sapiens (human)
detection of temperature stimulus involved in sensory perception of painStromal cell-derived factor 1Homo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painStromal cell-derived factor 1Homo sapiens (human)
cell chemotaxisStromal cell-derived factor 1Homo sapiens (human)
chemokine-mediated signaling pathwayStromal cell-derived factor 1Homo sapiens (human)
positive regulation of monocyte chemotaxisStromal cell-derived factor 1Homo sapiens (human)
positive regulation of calcium ion importStromal cell-derived factor 1Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damageStromal cell-derived factor 1Homo sapiens (human)
negative regulation of leukocyte tethering or rollingStromal cell-derived factor 1Homo sapiens (human)
positive regulation of vasculature developmentStromal cell-derived factor 1Homo sapiens (human)
response to ultrasoundStromal cell-derived factor 1Homo sapiens (human)
cellular response to chemokineStromal cell-derived factor 1Homo sapiens (human)
negative regulation of dendritic cell apoptotic processStromal cell-derived factor 1Homo sapiens (human)
positive regulation of cell migrationStromal cell-derived factor 1Homo sapiens (human)
induction of positive chemotaxisStromal cell-derived factor 1Homo sapiens (human)
axon guidanceStromal cell-derived factor 1Homo sapiens (human)
osteoblast differentiation10 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein folding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic process10 kDa heat shock protein, mitochondrialHomo sapiens (human)
response to unfolded protein10 kDa heat shock protein, mitochondrialHomo sapiens (human)
chaperone cofactor-dependent protein refolding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
negative regulation of inflammatory response to antigenic stimulusGuanine nucleotide-binding protein GHomo sapiens (human)
renal water homeostasisGuanine nucleotide-binding protein GHomo sapiens (human)
G protein-coupled receptor signaling pathwayGuanine nucleotide-binding protein GHomo sapiens (human)
regulation of insulin secretionGuanine nucleotide-binding protein GHomo sapiens (human)
cellular response to glucagon stimulusGuanine nucleotide-binding protein GHomo sapiens (human)
xanthine catabolic processXanthine dehydrogenase/oxidaseBos taurus (cattle)
follicular dendritic cell differentiationNuclear factor NF-kappa-B p100 subunit Homo sapiens (human)
germinal center formationNuclear factor NF-kappa-B p100 subunit Homo sapiens (human)
regulation of DNA-templated transcriptionNuclear factor NF-kappa-B p100 subunit Homo sapiens (human)
canonical NF-kappaB signal transductionNuclear factor NF-kappa-B p100 subunit Homo sapiens (human)
extracellular matrix organizationNuclear factor NF-kappa-B p100 subunit Homo sapiens (human)
response to lipopolysaccharideNuclear factor NF-kappa-B p100 subunit Homo sapiens (human)
positive regulation of transcription by RNA polymerase IINuclear factor NF-kappa-B p100 subunit Homo sapiens (human)
rhythmic processNuclear factor NF-kappa-B p100 subunit Homo sapiens (human)
spleen developmentNuclear factor NF-kappa-B p100 subunit Homo sapiens (human)
cellular response to stressNuclear factor NF-kappa-B p100 subunit Homo sapiens (human)
innate immune responseNuclear factor NF-kappa-B p100 subunit Homo sapiens (human)
non-canonical NF-kappaB signal transductionNuclear factor NF-kappa-B p100 subunit Homo sapiens (human)
response to cytokineNuclear factor NF-kappa-B p100 subunit Homo sapiens (human)
inflammatory responseNuclear factor NF-kappa-B p100 subunit Homo sapiens (human)
positive regulation of interleukin-1 beta productionTranscription factor p65Homo sapiens (human)
positive regulation of interleukin-6 productionTranscription factor p65Homo sapiens (human)
positive regulation of interleukin-8 productionTranscription factor p65Homo sapiens (human)
positive regulation of amyloid-beta formationTranscription factor p65Homo sapiens (human)
positive regulation of NF-kappaB transcription factor activityTranscription factor p65Homo sapiens (human)
nucleotide-binding oligomerization domain containing 2 signaling pathwayTranscription factor p65Homo sapiens (human)
negative regulation of transcription by RNA polymerase IITranscription factor p65Homo sapiens (human)
liver developmentTranscription factor p65Homo sapiens (human)
hair follicle developmentTranscription factor p65Homo sapiens (human)
defense response to tumor cellTranscription factor p65Homo sapiens (human)
response to ischemiaTranscription factor p65Homo sapiens (human)
acetaldehyde metabolic processTranscription factor p65Homo sapiens (human)
chromatin organizationTranscription factor p65Homo sapiens (human)
DNA-templated transcriptionTranscription factor p65Homo sapiens (human)
regulation of DNA-templated transcriptionTranscription factor p65Homo sapiens (human)
regulation of transcription by RNA polymerase IITranscription factor p65Homo sapiens (human)
inflammatory responseTranscription factor p65Homo sapiens (human)
cellular defense responseTranscription factor p65Homo sapiens (human)
neuropeptide signaling pathwayTranscription factor p65Homo sapiens (human)
canonical NF-kappaB signal transductionTranscription factor p65Homo sapiens (human)
positive regulation of cell population proliferationTranscription factor p65Homo sapiens (human)
response to xenobiotic stimulusTranscription factor p65Homo sapiens (human)
animal organ morphogenesisTranscription factor p65Homo sapiens (human)
response to UV-BTranscription factor p65Homo sapiens (human)
positive regulation of vascular endothelial growth factor productionTranscription factor p65Homo sapiens (human)
positive regulation of gene expressionTranscription factor p65Homo sapiens (human)
positive regulation of Schwann cell differentiationTranscription factor p65Homo sapiens (human)
negative regulation of angiogenesisTranscription factor p65Homo sapiens (human)
cytokine-mediated signaling pathwayTranscription factor p65Homo sapiens (human)
protein catabolic processTranscription factor p65Homo sapiens (human)
response to muramyl dipeptideTranscription factor p65Homo sapiens (human)
response to progesteroneTranscription factor p65Homo sapiens (human)
positive regulation of interleukin-12 productionTranscription factor p65Homo sapiens (human)
positive regulation of interleukin-6 productionTranscription factor p65Homo sapiens (human)
positive regulation of interleukin-8 productionTranscription factor p65Homo sapiens (human)
response to insulinTranscription factor p65Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayTranscription factor p65Homo sapiens (human)
negative regulation of protein sumoylationTranscription factor p65Homo sapiens (human)
response to cobalaminTranscription factor p65Homo sapiens (human)
toll-like receptor 4 signaling pathwayTranscription factor p65Homo sapiens (human)
intracellular signal transductionTranscription factor p65Homo sapiens (human)
cellular response to hepatocyte growth factor stimulusTranscription factor p65Homo sapiens (human)
response to muscle stretchTranscription factor p65Homo sapiens (human)
non-canonical NF-kappaB signal transductionTranscription factor p65Homo sapiens (human)
vascular endothelial growth factor signaling pathwayTranscription factor p65Homo sapiens (human)
prolactin signaling pathwayTranscription factor p65Homo sapiens (human)
negative regulation of protein catabolic processTranscription factor p65Homo sapiens (human)
negative regulation of apoptotic processTranscription factor p65Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionTranscription factor p65Homo sapiens (human)
response to amino acidTranscription factor p65Homo sapiens (human)
negative regulation of DNA-templated transcriptionTranscription factor p65Homo sapiens (human)
positive regulation of DNA-templated transcriptionTranscription factor p65Homo sapiens (human)
positive regulation of transcription by RNA polymerase IITranscription factor p65Homo sapiens (human)
negative regulation of insulin receptor signaling pathwayTranscription factor p65Homo sapiens (human)
regulation of inflammatory responseTranscription factor p65Homo sapiens (human)
positive regulation of T cell receptor signaling pathwayTranscription factor p65Homo sapiens (human)
positive regulation of NF-kappaB transcription factor activityTranscription factor p65Homo sapiens (human)
response to cAMPTranscription factor p65Homo sapiens (human)
defense response to virusTranscription factor p65Homo sapiens (human)
cellular response to hydrogen peroxideTranscription factor p65Homo sapiens (human)
interleukin-1-mediated signaling pathwayTranscription factor p65Homo sapiens (human)
response to interleukin-1Transcription factor p65Homo sapiens (human)
cellular response to lipopolysaccharideTranscription factor p65Homo sapiens (human)
cellular response to lipoteichoic acidTranscription factor p65Homo sapiens (human)
cellular response to peptidoglycanTranscription factor p65Homo sapiens (human)
cellular response to nicotineTranscription factor p65Homo sapiens (human)
cellular response to interleukin-1Transcription factor p65Homo sapiens (human)
cellular response to interleukin-6Transcription factor p65Homo sapiens (human)
cellular response to tumor necrosis factorTranscription factor p65Homo sapiens (human)
postsynapse to nucleus signaling pathwayTranscription factor p65Homo sapiens (human)
antiviral innate immune responseTranscription factor p65Homo sapiens (human)
negative regulation of non-canonical NF-kappaB signal transductionTranscription factor p65Homo sapiens (human)
positive regulation of non-canonical NF-kappaB signal transductionTranscription factor p65Homo sapiens (human)
negative regulation of miRNA transcriptionTranscription factor p65Homo sapiens (human)
positive regulation of miRNA transcriptionTranscription factor p65Homo sapiens (human)
cellular response to angiotensinTranscription factor p65Homo sapiens (human)
positive regulation of leukocyte adhesion to vascular endothelial cellTranscription factor p65Homo sapiens (human)
positive regulation of miRNA metabolic processTranscription factor p65Homo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathwayTranscription factor p65Homo sapiens (human)
cellular response to stressTranscription factor p65Homo sapiens (human)
response to cytokineTranscription factor p65Homo sapiens (human)
innate immune responseTranscription factor p65Homo sapiens (human)
sulfur amino acid catabolic processThiosulfate sulfurtransferaseHomo sapiens (human)
cyanate catabolic processThiosulfate sulfurtransferaseHomo sapiens (human)
epithelial cell differentiationThiosulfate sulfurtransferaseHomo sapiens (human)
rRNA import into mitochondrionThiosulfate sulfurtransferaseHomo sapiens (human)
rRNA transportThiosulfate sulfurtransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (65)

Processvia Protein(s)Taxonomy
magnesium ion binding60 kDa chaperoninEscherichia coli K-12
protein binding60 kDa chaperoninEscherichia coli K-12
ATP binding60 kDa chaperoninEscherichia coli K-12
isomerase activity60 kDa chaperoninEscherichia coli K-12
ATP hydrolysis activity60 kDa chaperoninEscherichia coli K-12
identical protein binding60 kDa chaperoninEscherichia coli K-12
unfolded protein binding60 kDa chaperoninEscherichia coli K-12
ATP-dependent protein folding chaperone60 kDa chaperoninEscherichia coli K-12
lipopolysaccharide binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
p53 binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
DNA replication origin binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
single-stranded DNA binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
RNA binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
double-stranded RNA binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
ATP binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
high-density lipoprotein particle binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
isomerase activity60 kDa heat shock protein, mitochondrialHomo sapiens (human)
ATP hydrolysis activity60 kDa heat shock protein, mitochondrialHomo sapiens (human)
enzyme binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
ubiquitin protein ligase binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
apolipoprotein binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
apolipoprotein A-I binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
unfolded protein binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein-folding chaperone binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
ATP-dependent protein folding chaperone60 kDa heat shock protein, mitochondrialHomo sapiens (human)
transcription cis-regulatory region bindingNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
RNA polymerase II transcription regulatory region sequence-specific DNA bindingNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
chromatin bindingNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
DNA-binding transcription factor activityNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
transcription coregulator activityNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
protein bindingNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
identical protein bindingNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
actinin bindingNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
signaling receptor bindingStromal cell-derived factor 1Homo sapiens (human)
integrin bindingStromal cell-derived factor 1Homo sapiens (human)
protein bindingStromal cell-derived factor 1Homo sapiens (human)
chemokine activityStromal cell-derived factor 1Homo sapiens (human)
growth factor activityStromal cell-derived factor 1Homo sapiens (human)
chemokine receptor bindingStromal cell-derived factor 1Homo sapiens (human)
CXCR chemokine receptor bindingStromal cell-derived factor 1Homo sapiens (human)
RNA binding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein binding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
ATP binding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein folding chaperone10 kDa heat shock protein, mitochondrialHomo sapiens (human)
unfolded protein binding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein-folding chaperone binding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
metal ion binding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
G protein activityGuanine nucleotide-binding protein GHomo sapiens (human)
adenylate cyclase activator activityGuanine nucleotide-binding protein GHomo sapiens (human)
xanthine dehydrogenase activityXanthine dehydrogenase/oxidaseBos taurus (cattle)
xanthine oxidase activityXanthine dehydrogenase/oxidaseBos taurus (cattle)
iron ion bindingXanthine dehydrogenase/oxidaseBos taurus (cattle)
molybdenum ion bindingXanthine dehydrogenase/oxidaseBos taurus (cattle)
protein homodimerization activityXanthine dehydrogenase/oxidaseBos taurus (cattle)
molybdopterin cofactor bindingXanthine dehydrogenase/oxidaseBos taurus (cattle)
flavin adenine dinucleotide bindingXanthine dehydrogenase/oxidaseBos taurus (cattle)
2 iron, 2 sulfur cluster bindingXanthine dehydrogenase/oxidaseBos taurus (cattle)
FAD bindingXanthine dehydrogenase/oxidaseBos taurus (cattle)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear factor NF-kappa-B p100 subunit Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear factor NF-kappa-B p100 subunit Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificNuclear factor NF-kappa-B p100 subunit Homo sapiens (human)
DNA-binding transcription factor activityNuclear factor NF-kappa-B p100 subunit Homo sapiens (human)
protein bindingNuclear factor NF-kappa-B p100 subunit Homo sapiens (human)
sequence-specific double-stranded DNA bindingNuclear factor NF-kappa-B p100 subunit Homo sapiens (human)
transcription cis-regulatory region bindingTranscription factor p65Homo sapiens (human)
RNA polymerase II transcription regulatory region sequence-specific DNA bindingTranscription factor p65Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingTranscription factor p65Homo sapiens (human)
RNA polymerase II core promoter sequence-specific DNA bindingTranscription factor p65Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificTranscription factor p65Homo sapiens (human)
transcription coactivator bindingTranscription factor p65Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificTranscription factor p65Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificTranscription factor p65Homo sapiens (human)
DNA bindingTranscription factor p65Homo sapiens (human)
chromatin bindingTranscription factor p65Homo sapiens (human)
DNA-binding transcription factor activityTranscription factor p65Homo sapiens (human)
protein bindingTranscription factor p65Homo sapiens (human)
enzyme bindingTranscription factor p65Homo sapiens (human)
protein kinase bindingTranscription factor p65Homo sapiens (human)
chromatin DNA bindingTranscription factor p65Homo sapiens (human)
ubiquitin protein ligase bindingTranscription factor p65Homo sapiens (human)
peptide bindingTranscription factor p65Homo sapiens (human)
phosphate ion bindingTranscription factor p65Homo sapiens (human)
identical protein bindingTranscription factor p65Homo sapiens (human)
protein homodimerization activityTranscription factor p65Homo sapiens (human)
actinin bindingTranscription factor p65Homo sapiens (human)
histone deacetylase bindingTranscription factor p65Homo sapiens (human)
NF-kappaB bindingTranscription factor p65Homo sapiens (human)
ankyrin repeat bindingTranscription factor p65Homo sapiens (human)
general transcription initiation factor bindingTranscription factor p65Homo sapiens (human)
DNA-binding transcription factor bindingTranscription factor p65Homo sapiens (human)
thiosulfate sulfurtransferase activityThiosulfate sulfurtransferaseHomo sapiens (human)
5S rRNA bindingThiosulfate sulfurtransferaseHomo sapiens (human)
3-mercaptopyruvate sulfurtransferase activityThiosulfate sulfurtransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (37)

Processvia Protein(s)Taxonomy
cytoplasm60 kDa chaperoninEscherichia coli K-12
cytosol60 kDa chaperoninEscherichia coli K-12
membrane60 kDa chaperoninEscherichia coli K-12
GroEL-GroES complex60 kDa chaperoninEscherichia coli K-12
mitochondrial matrix60 kDa heat shock protein, mitochondrialHomo sapiens (human)
extracellular space60 kDa heat shock protein, mitochondrialHomo sapiens (human)
cytoplasm60 kDa heat shock protein, mitochondrialHomo sapiens (human)
mitochondrion60 kDa heat shock protein, mitochondrialHomo sapiens (human)
mitochondrial inner membrane60 kDa heat shock protein, mitochondrialHomo sapiens (human)
mitochondrial matrix60 kDa heat shock protein, mitochondrialHomo sapiens (human)
early endosome60 kDa heat shock protein, mitochondrialHomo sapiens (human)
cytosol60 kDa heat shock protein, mitochondrialHomo sapiens (human)
plasma membrane60 kDa heat shock protein, mitochondrialHomo sapiens (human)
clathrin-coated pit60 kDa heat shock protein, mitochondrialHomo sapiens (human)
cell surface60 kDa heat shock protein, mitochondrialHomo sapiens (human)
membrane60 kDa heat shock protein, mitochondrialHomo sapiens (human)
coated vesicle60 kDa heat shock protein, mitochondrialHomo sapiens (human)
secretory granule60 kDa heat shock protein, mitochondrialHomo sapiens (human)
extracellular exosome60 kDa heat shock protein, mitochondrialHomo sapiens (human)
sperm midpiece60 kDa heat shock protein, mitochondrialHomo sapiens (human)
sperm plasma membrane60 kDa heat shock protein, mitochondrialHomo sapiens (human)
migrasome60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein-containing complex60 kDa heat shock protein, mitochondrialHomo sapiens (human)
lipopolysaccharide receptor complex60 kDa heat shock protein, mitochondrialHomo sapiens (human)
mitochondrial inner membrane60 kDa heat shock protein, mitochondrialHomo sapiens (human)
extracellular regionNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
nucleusNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
nucleoplasmNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
cytoplasmNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
mitochondrionNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
cytosolNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
secretory granule lumenNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
specific granule lumenNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
chromatinNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
transcription regulator complexNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
I-kappaB/NF-kappaB complexNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
nucleusNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
cytoplasmNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
NF-kappaB p50/p65 complexNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
extracellular regionStromal cell-derived factor 1Homo sapiens (human)
collagen-containing extracellular matrixStromal cell-derived factor 1Homo sapiens (human)
extracellular exosomeStromal cell-derived factor 1Homo sapiens (human)
external side of plasma membraneStromal cell-derived factor 1Homo sapiens (human)
mitochondrion10 kDa heat shock protein, mitochondrialHomo sapiens (human)
membrane10 kDa heat shock protein, mitochondrialHomo sapiens (human)
extracellular exosome10 kDa heat shock protein, mitochondrialHomo sapiens (human)
mitochondrial matrix10 kDa heat shock protein, mitochondrialHomo sapiens (human)
plasma membraneGuanine nucleotide-binding protein GHomo sapiens (human)
extracellular spaceXanthine dehydrogenase/oxidaseBos taurus (cattle)
peroxisomeXanthine dehydrogenase/oxidaseBos taurus (cattle)
xanthine dehydrogenase complexXanthine dehydrogenase/oxidaseBos taurus (cattle)
nucleusNuclear factor NF-kappa-B p100 subunit Homo sapiens (human)
nucleoplasmNuclear factor NF-kappa-B p100 subunit Homo sapiens (human)
cytoplasmNuclear factor NF-kappa-B p100 subunit Homo sapiens (human)
cytosolNuclear factor NF-kappa-B p100 subunit Homo sapiens (human)
chromatinNuclear factor NF-kappa-B p100 subunit Homo sapiens (human)
Bcl3/NF-kappaB2 complexNuclear factor NF-kappa-B p100 subunit Homo sapiens (human)
cytoplasmNuclear factor NF-kappa-B p100 subunit Homo sapiens (human)
nucleusNuclear factor NF-kappa-B p100 subunit Homo sapiens (human)
nucleolusTranscription factor p65Homo sapiens (human)
nucleusTranscription factor p65Homo sapiens (human)
glutamatergic synapseTranscription factor p65Homo sapiens (human)
nucleusTranscription factor p65Homo sapiens (human)
nucleoplasmTranscription factor p65Homo sapiens (human)
cytoplasmTranscription factor p65Homo sapiens (human)
cytosolTranscription factor p65Homo sapiens (human)
NF-kappaB p50/p65 complexTranscription factor p65Homo sapiens (human)
NF-kappaB complexTranscription factor p65Homo sapiens (human)
chromatinTranscription factor p65Homo sapiens (human)
transcription regulator complexTranscription factor p65Homo sapiens (human)
cytoplasmTranscription factor p65Homo sapiens (human)
extracellular spaceThiosulfate sulfurtransferaseHomo sapiens (human)
mitochondrionThiosulfate sulfurtransferaseHomo sapiens (human)
mitochondrial matrixThiosulfate sulfurtransferaseHomo sapiens (human)
mitochondrionThiosulfate sulfurtransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (110)

Assay IDTitleYearJournalArticle
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID386986Antifungal activity against haploid Saccharomyces cerevisiae 10560-6B by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1142307Inhibition of NF-kappaB transactivation in TNF-alpha-stimulated human K562 cells preincubated for 2 hrs followed by TNF-alpha challenge measured after 6 hrs by dual luciferase reporter gene assay2014Bioorganic & medicinal chemistry, Jun-01, Volume: 22, Issue:11
Bis(4-hydroxy-2H-chromen-2-one): synthesis and effects on leukemic cell lines proliferation and NF-κB regulation.
AID144377Ability to induce NAD(P)H quinone reductase activity in cultured Hepa 1c1c7 murine hepatoma cells.1998Journal of medicinal chemistry, Dec-17, Volume: 41, Issue:26
Chemoprotective properties of phenylpropenoids, bis(benzylidene)cycloalkanones, and related Michael reaction acceptors: correlation of potencies as phase 2 enzyme inducers and radical scavengers.
AID1896712Inhibition of refolded rhodanese reporter enzyme (unknown origin)2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID386987Antifungal activity against haploid Saccharomyces cerevisiae YSH1170 by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID386985Antifungal activity against haploid Saccharomyces cerevisiae FY4 by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1594137Inhibition of ATPase activity of Escherichia coli GroEL expressed in Escherichia coliDH5alpha incubated for 60 mins using ATP by spectrometric analysis2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID1272632Inhibition of bovine xanthine oxidase assessed as conversion of xanthine to uric acid by spectroscopic analysis2016Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
Hydroxylated chalcones with dual properties: Xanthine oxidase inhibitors and radical scavengers.
AID1594140Inhibition of Escherichia coli GroEL expressed in Escherichia coli DH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured rhodanese refolding by measuring rhodanese enzyme activity 2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID387002Antifungal activity against Hansenula polymorpha AU05 with ade3 ura3 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID257317Inhibitory activity against barley beta amylase at 200 uM2005Bioorganic & medicinal chemistry letters, Dec-15, Volume: 15, Issue:24
Sulfonamide chalcone as a new class of alpha-glucosidase inhibitors.
AID386984Antifungal activity against haploid Saccharomyces cerevisiae D3C by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID372908Antibacterial activity against Staphylococcus aureus Rosenbach 209 after 24 hrs by serial dilution method2009European journal of medicinal chemistry, May, Volume: 44, Issue:5
Examination of growth inhibitory properties of synthetic chalcones for which antibacterial activity was predicted.
AID99076Concentration required to inhibit 50% growth of L1210 leukemia cells1998Journal of medicinal chemistry, Mar-26, Volume: 41, Issue:7
Cytotoxic activities of Mannich bases of chalcones and related compounds.
AID372907Antibacterial activity against Staphylococcus aureus Rosenbach 209 after 48 hrs by agar well diffusion method2009European journal of medicinal chemistry, May, Volume: 44, Issue:5
Examination of growth inhibitory properties of synthetic chalcones for which antibacterial activity was predicted.
AID386989Antifungal activity against Hansenula polymorpha WT1 with ade1 ura3 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID283847Antifungal activity against Candida albicans Berhaut 62I after 24 hrs2007European journal of medicinal chemistry, Jan, Volume: 42, Issue:1
Study on the substituents' effects of a series of synthetic chalcones against the yeast Candida albicans.
AID386981Antifungal activity against diploid Saccharomyces cerevisiae 1a by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1896715Cytotoxicity against human DLD-1 cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID1594139Inhibition of human N-terminal octa-His-tagged HSP60 expressed in Escherichia coli Rosetta(DE3) pLysS/human HSP10 expressed in Escherichia coli Rosetta(DE3) assessed as reduction in HSP60/HSP10-mediated denatured MDH refolding by measuring MDH enzyme acti2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID386992Antifungal activity against Hansenula polymorpha CD2 with ade1 leu2 cds2 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID88789Concentration required to inhibit 50% growth of Human CEM T-lymphocytes cells1998Journal of medicinal chemistry, Mar-26, Volume: 41, Issue:7
Cytotoxic activities of Mannich bases of chalcones and related compounds.
AID551964Cytotoxicity against mouse NIH/3T3 cells assessed as cell viability after 8 hrs2011Bioorganic & medicinal chemistry letters, Jan-01, Volume: 21, Issue:1
Chalcone-based inhibitors against hypoxia-inducible factor 1--structure activity relationship studies.
AID372906Antibacterial activity against Escherichia coli WF+2009European journal of medicinal chemistry, May, Volume: 44, Issue:5
Examination of growth inhibitory properties of synthetic chalcones for which antibacterial activity was predicted.
AID1896710Inhibition of Escherichia coli GroEL expressed in NEB-5-alpha Escherichia coli cells/Escherichia coli GroES expressed in Escherichia coli BL21(DE3) cells assessed as inhibition of GroEL/ES-mediated dRho refolding by reporter analysis2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID387008Antifungal activity against Kluyveromyces lactis 2-19B with MATalpha ura lys arg genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID670944Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 at 102.4 mg/ml after 24 hrs by disc diffusion method2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Synthesis and anti Methicillin resistant Staphylococcus aureus activity of substituted chalcones alone and in combination with non-beta-lactam antibiotics.
AID386996Antifungal activity against Hansenula polymorpha 2b with arg1 ade1 leu2 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1698237Inhibition of PMA-induce ROS/RNS generation in human neutrophils measured up to 30 mins in presence of 5.5 mM glucose by luminol-amplified chemiluminescence method2020Journal of natural products, 10-23, Volume: 83, Issue:10
Chalcones as Modulators of Neutrophil Oxidative Burst under Physiological and High Glucose Conditions.
AID1461521Antioxidant activity assessed as DPPH free radical scavenging activity incubated for 30 mins at 2000 uM2017Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
Synthesis and evaluation of hydroxychalcones as multifunctional non-purine xanthine oxidase inhibitors for the treatment of hyperuricemia.
AID1594134Inhibition of native soluble pig heart MDH assessed as reduction in MDH enzyme activity using sodium mesoxalate as substrate and NADH by malachite green dye based spectrometric analysis2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID386977Antifungal activity against diploid Saccharomyces cerevisiae PV-2 by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1896713Inhibition of refolded MDH reporter enzyme (unknown origin)2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID1594135Inhibition of native rhodanese (unknown origin) assessed as reduction in rhodanese enzyme activity after 45 mins by Fe(SCN)3 dye based spectrometric analysis2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID283849Antifungal activity against Candida albicans Berhaut 62I in meat-pepton broth2007European journal of medicinal chemistry, Jan, Volume: 42, Issue:1
Study on the substituents' effects of a series of synthetic chalcones against the yeast Candida albicans.
AID1272634Cytoprotective activity against amyloid beta-induced oxidative stress in mouse Neuro2a cells assessed as cell viability at 250 uM after 6 hrs by MTT assay2016Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
Hydroxylated chalcones with dual properties: Xanthine oxidase inhibitors and radical scavengers.
AID1896709Inhibition of Escherichia coli GroEL expressed in NEB-5-alpha Escherichia coli cells/Escherichia coli GroES expressed in Escherichia coli BL21(DE3) cells assessed as inhibition of GroEL/ES-mediated dMDH refolding by reporter analysis2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID1594143Selectivity index, ratio of IC50 for inhibition of native rhodanese (unknown origin) to IC50 for inhibition of Escherichia coli GroEL expressed in Escherichia coliDH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reducti2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID386988Antifungal activity against haploid Saccharomyces cerevisiae YSH1171 by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1896720Selectivity index, ratio of CC50 for cytotoxicity against non-cancerous cells to EC50 for cytotoxicity against human HCT-116 cells2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID670963Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 after 24 hrs by microdilution method in presence of non-beta lactam antibiotic Doxycycline2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Synthesis and anti Methicillin resistant Staphylococcus aureus activity of substituted chalcones alone and in combination with non-beta-lactam antibiotics.
AID1896711Inhibition of human mitochondrial HSP60 expressed in Escherichia coli Rosetta 2 (DE3) cells/human mitochondrial HSP10 expressed in Escherichia coli Rosetta 2 (DE3) pLysS cells assessed as inhibition of GroEL/ES-mediated dMDH refolding by reporter analysis2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID386995Antifungal activity against Hansenula polymorpha 2a with arg1 leu2 ura3 cys1 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID387007Antifungal activity against Kluyveromyces lactis 1-6A with MATalpha uraA lys arg genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1698231Effect on cell viability in human neutrophils assessed as decrease in cell viability at 50 uM after 1 hr by Propidium staining based flow cytometric analysis2020Journal of natural products, 10-23, Volume: 83, Issue:10
Chalcones as Modulators of Neutrophil Oxidative Burst under Physiological and High Glucose Conditions.
AID1461520Antioxidant activity assessed as ABTS free radical scavenging activity by measuring trolox equivalents after 6 mins2017Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
Synthesis and evaluation of hydroxychalcones as multifunctional non-purine xanthine oxidase inhibitors for the treatment of hyperuricemia.
AID387001Antifungal activity against Hansenula polymorpha M4 with met4 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1896717Cytotoxicity against p53-/- human HCT-116 cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID387000Antifungal activity against Hansenula polymorpha AS1 with arg1 gsh2delta genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID89118Concentration required to inhibit 50% growth of human Molt 4/C8 T-lymphocyte cells1998Journal of medicinal chemistry, Mar-26, Volume: 41, Issue:7
Cytotoxic activities of Mannich bases of chalcones and related compounds.
AID387003Antifungal activity against Hansenula polymorpha CTA1 with leu2 cat1 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1461517Inhibition of bovine milk xanthine oxidase pre-incubated for 30 mins followed by xanthine addition and measured every 30 secs for 5 mins by spectrophotometry2017Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
Synthesis and evaluation of hydroxychalcones as multifunctional non-purine xanthine oxidase inhibitors for the treatment of hyperuricemia.
AID1594138Selectivity index, ratio of IC50 for inhibition of native soluble pig heart MDH to IC50 for inhibition of Escherichia coli GroEL expressed in Escherichia coli DH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction i2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID386980Antifungal activity against haploid Saccharomyces cerevisiae 2180 by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID670959Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 after 24 hrs by microdilution method2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Synthesis and anti Methicillin resistant Staphylococcus aureus activity of substituted chalcones alone and in combination with non-beta-lactam antibiotics.
AID257316Inhibitory activity against Bacillus licheniformis alpha amylase at 200 uM2005Bioorganic & medicinal chemistry letters, Dec-15, Volume: 15, Issue:24
Sulfonamide chalcone as a new class of alpha-glucosidase inhibitors.
AID1272633Antioxidant activity assessed as DPPH radical scavenging activity by measuring remaining DPPH level at 20 uM after 30 mins by plate reader analysis2016Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
Hydroxylated chalcones with dual properties: Xanthine oxidase inhibitors and radical scavengers.
AID1698242Inhibition of PMA-induce ROS/RNS generation in human neutrophils measured up to 30 mins in presence of 30 mM glucose by luminol-amplified chemiluminescence method2020Journal of natural products, 10-23, Volume: 83, Issue:10
Chalcones as Modulators of Neutrophil Oxidative Burst under Physiological and High Glucose Conditions.
AID313629Blockade of human K+ channel in HEK293 cells assessed as inhibition of outward delayed rectifying K+ current2008Bioorganic & medicinal chemistry letters, Jan-01, Volume: 18, Issue:1
Sulfonate chalcone as new class voltage-dependent K+ channel blocker.
AID670951Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 43300 at 102.4 mg/ml after 24 hrs by disc diffusion method2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Synthesis and anti Methicillin resistant Staphylococcus aureus activity of substituted chalcones alone and in combination with non-beta-lactam antibiotics.
AID670961Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 after 24 hrs by microdilution method in presence of non-beta lactam antibiotic ciprofloxacin2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Synthesis and anti Methicillin resistant Staphylococcus aureus activity of substituted chalcones alone and in combination with non-beta-lactam antibiotics.
AID1896714Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID1594141Inhibition of Escherichia coli GroEL expressed in Escherichia coliDH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured soluble pig heart MDH refolding by measuring MDH enzyme acti2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID386994Antifungal activity against Hansenula polymorpha WA1 with ade1 leu2 gsh1 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID150684Inhibition of proliferation of murine P388 cells1998Journal of medicinal chemistry, Mar-26, Volume: 41, Issue:7
Cytotoxic activities of Mannich bases of chalcones and related compounds.
AID257315Inhibitory activity against baker's yeast alpha glucosidase at 200 uM2005Bioorganic & medicinal chemistry letters, Dec-15, Volume: 15, Issue:24
Sulfonamide chalcone as a new class of alpha-glucosidase inhibitors.
AID386978Antifungal activity against diploid Saccharomyces cerevisiae PV-3 by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID386997Antifungal activity against Hansenula polymorpha D22 with arg1/arg1 ade1/ADE1 leu2/leu2 URA3/ura3 CYS1/cys1 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID387005Antifungal activity against Hansenula polymorpha CRD2 with leu2 CDR2 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID386991Antifungal activity against Hansenula polymorpha CD1 with ade1 leu2 cds1 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID255211Inhibitory concentration against recombinant rat androgen receptor expressed in Escherichia coli using [3H]methyltrienolone (R 1881)2005Journal of medicinal chemistry, Sep-08, Volume: 48, Issue:18
Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals.
AID443496Inhibition of TNFalpha induced NF-kappaB activation in human A549 cells by luciferase reporter gene assay2009Journal of medicinal chemistry, Nov-26, Volume: 52, Issue:22
Structure-activity relationship studies of chalcone leading to 3-hydroxy-4,3',4',5'-tetramethoxychalcone and its analogues as potent nuclear factor kappaB inhibitors and their anticancer activities.
AID1594144Inhibition of Escherichia coli GroEL expressed in Escherichia coliDH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured soluble pig heart MDH refolding by measuring MDH enzyme acti2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID1896716Cytotoxicity against human HT-29 cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID1896718Cytotoxicity against human FHs74Int cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID386990Antifungal activity against Hansenula polymorpha WT2 with ade1 met6 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1594136Selectivity index, ratio of IC50 for inhibition of native soluble pig heart MDH to IC50 for inhibition of Escherichia coli GroEL expressed in Escherichia coliDH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID386976Antifungal activity against haploid Saccharomyces cerevisiae 1S by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID386998Antifungal activity against Hansenula polymorpha M2 with met2 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID387004Antifungal activity against Hansenula polymorpha R3 with rgh3 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1594142Selectivity index, ratio of IC50 for inhibition of native rhodanese (unknown origin) to IC50 for inhibition of Escherichia coli GroEL expressed in Escherichia coli DH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduct2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID1594145Inhibition of Escherichia coli GroEL expressed in Escherichia coli DH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured rhodanese refolding by measuring rhodanese enzyme activity 2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID661075Antidiabetic activity in mouse 3T3L1 cells assessed as decrease in glucose consumption from cell culture medium using 450 mg/dL D-glucose at 30 ug/mL after 24 hrs (Rvb = 310 +/- 4 mg/dl)2012Bioorganic & medicinal chemistry letters, Jun-15, Volume: 22, Issue:12
Synthesis of chalcone derivatives as potential anti-diabetic agents.
AID551962Inhibition of cobalt chloride-induced HIF-1 activation expressed in mouse NIH3T3 cells after 8 hrs by luciferase reporter gene assay2011Bioorganic & medicinal chemistry letters, Jan-01, Volume: 21, Issue:1
Chalcone-based inhibitors against hypoxia-inducible factor 1--structure activity relationship studies.
AID1244004Anti-leishmanial activity against Leishmania major2015European journal of medicinal chemistry, Aug-28, Volume: 101Chalcone scaffolds as anti-infective agents: structural and molecular target perspectives.
AID1896719Cytotoxicity against human FHC cells assessed as reduction in cell viability incubated for 48 hrs by AlamarBlue-based assay2022Bioorganic & medicinal chemistry, Oct-30, Volume: 75Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosol.
AID386993Antifungal activity against Hansenula polymorpha CD3 with ade1 leu2 cds3 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID386999Antifungal activity against Hansenula polymorpha MC1 with met2 cys1 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID283848Growth inhibition of Candida albicans Berhaut 62I by agar cup method2007European journal of medicinal chemistry, Jan, Volume: 42, Issue:1
Study on the substituents' effects of a series of synthetic chalcones against the yeast Candida albicans.
AID670964Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 after 24 hrs by microdilution method in presence of non-beta lactam antibiotic ciprofloxacin2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Synthesis and anti Methicillin resistant Staphylococcus aureus activity of substituted chalcones alone and in combination with non-beta-lactam antibiotics.
AID387006Antifungal activity against Kluyveromyces lactis 2-18B with MATalpha metA1 ura3 leu2 genotype by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID670958Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 after 24 hrs by microdilution method2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Synthesis and anti Methicillin resistant Staphylococcus aureus activity of substituted chalcones alone and in combination with non-beta-lactam antibiotics.
AID386979Antifungal activity against haploid Saccharomyces cerevisiae 1169 by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID386982Antifungal activity against diploid Saccharomyces cerevisiae 29a by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID386983Antifungal activity against haploid Saccharomyces cerevisiae Sigma 1278b by agar dilution method2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
Antifungal activity of chalcones: a mechanistic study using various yeast strains.
AID1799680Enzyme Inhibition Assay from Article 10.1080/14756360400015231: \\Synthesis and inhibitory potential towards acetylcholinesterase, butyrylcholinesterase and lipoxygenase of some variably substituted chalcones.\\2005Journal of enzyme inhibition and medicinal chemistry, Feb, Volume: 20, Issue:1
Synthesis and inhibitory potential towards acetylcholinesterase, butyrylcholinesterase and lipoxygenase of some variably substituted chalcones.
AID1799806Tryptophan Fluorescence Assay from Article 10.1074/jbc.M803947200: \\Small neutralizing molecules to inhibit actions of the chemokine CXCL12.\\2008The Journal of biological chemistry, Aug-22, Volume: 283, Issue:34
Small neutralizing molecules to inhibit actions of the chemokine CXCL12.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (37)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (5.41)18.2507
2000's12 (32.43)29.6817
2010's17 (45.95)24.3611
2020's6 (16.22)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.99

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.99 (24.57)
Research Supply Index3.64 (2.92)
Research Growth Index5.29 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.99)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.70%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other36 (97.30%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]